6 Feb 2020
Kleo Pharmaceuticals Receives IND Authorization to Proceed from FDA for its Multiple Myeloma Therapeutic
Author: admintech | Filed under: Press ReleaseNEW HAVEN, Conn., Feb. 6, 2020 /PRNewswire/ — Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced today that it has received Investigational New Drug…